Dana dhuwit diétung saben saham aptose.com (APTO)

Lambang korporat lan logo Aptose Biosciences (APTO)

The cash per share metric on the precise GURU.Markets chart demonstrates the liquidity of Aptose Biosciences Inc. (APTO), where 0.00 captures the current state of the parameter. Biotechnology capacities and partner plants are operating without disruption. Aptose Biosciences Inc. (APTO) integrates ESG principles and bioethics into the development of blood cancer therapies. High R&D expenditures are offset by patent protection and strict FDA oversight.

APTO aptose.com: Dhuwit awis saben siji saham ing interval 04.07.2022 - 13.04.2025

Rincian metrik komprehensif lan analitis Aptose Biosciences (APTO)

- rega pasar lan target rega analis:
- rincian posisi dhuwit lan arus kas:
Analisis komprehensif perusahaan:APTO (Aptose Biosciences Inc)
Produk merek aptose.com

Aptose Biosciences Inc. (APTO) focuses on developing innovative drugs for the treatment of hematological diseases. This metric determines the share of liquid assets per common share. By analyzing the cash per share structure, an investor tracks the dynamics of available capital in real-time. For a biotechnology company dependent on external financing, this indicator serves as a "margin of safety." It allows for an assessment of management's ability to sustain research without emergency secondary offerings.